Cargando…
Glycosaminoglycan Neutralization in Coagulation Control
The glycosaminoglycans (GAGs) heparan sulfate, dermatan sulfate, and heparin are important anticoagulants that inhibit clot formation through interactions with antithrombin and heparin cofactor II. Unfractionated heparin, low-molecular-weight heparin, and heparin-derived drugs are often the main tre...
Autores principales: | Sobczak, Amélie I.S., Pitt, Samantha J., Stewart, Alan J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5965931/ https://www.ncbi.nlm.nih.gov/pubmed/29674476 http://dx.doi.org/10.1161/ATVBAHA.118.311102 |
Ejemplares similares
-
Influence of zinc on glycosaminoglycan neutralisation during coagulation
por: Sobczak, Amélie I. S., et al.
Publicado: (2018) -
Total plasma magnesium, zinc, copper and selenium concentrations in type-I and type-II diabetes
por: Sobczak, Amélie I. S., et al.
Publicado: (2019) -
Coagulatory Defects in Type-1 and Type-2 Diabetes
por: Sobczak, Amélie I. S., et al.
Publicado: (2019) -
Lipidomic profiling of plasma free fatty acids in type-1 diabetes highlights specific changes in lipid metabolism
por: Sobczak, Amélie I.S., et al.
Publicado: (2021) -
Reduced Plasma Magnesium Levels in Type-1 Diabetes Associate with Prothrombotic Changes in Fibrin Clotting and Fibrinolysis
por: Sobczak, Amélie I. S., et al.
Publicado: (2020)